Partial dysfunction of Treg activation in sickle cell disease - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue American Journal of Hematology Année : 2013

Partial dysfunction of Treg activation in sickle cell disease

Résumé

Sickle cell disease (SCD) is a chronic inflammatory disease associated with multiple organ damage, chronic anemia, and infections. SCD patients have a high rate of alloimmunization against red blood cells (RBCs) following transfusion and may develop autoimmune diseases. Studies in mouse models have suggested that regulatory T cells (Treg) play a role in alloimmunization against RBC antigens. We characterized the phenotype and function of the Treg cell population in a homogeneous cohort of transfused SCD patients. We found that the distribution of Treg subpopulations differed significantly between SCD patients and healthy blood donors. SCD patients have a particular Treg phenotype, with strong CTLA-4 and CD39 expression and weak HLA-DR and CCR7 expression. Finally, we show that this particular phenotype is related to SCD rather than alloimmunization status. Indeed, we observed no difference in Treg phenotype or function in vitro using autologous feeder cells between strong and weak responders to alloimmunization.

Domaines

Immunologie
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03129789 , version 1 (03-02-2021)

Identifiants

Citer

Benoît Vingert, Marie Tamagne, Maxime Desmarets, Sadaf Pakdaman, Rahma Elayeb, et al.. Partial dysfunction of Treg activation in sickle cell disease. American Journal of Hematology, 2013, 89, pp.261 - 266. ⟨10.1002/ajh.23629⟩. ⟨inserm-03129789⟩

Collections

INSERM IMRB UPEC
43 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More